Literature DB >> 33650246

Targeting multiple enzymes in vitamin K metabolism for anticoagulation.

Weikai Li1.   

Abstract

Entities:  

Keywords:  anticoagulants; antidotes; vitamin K cycle; vitamin K epoxide reductases; warfarin

Mesh：

Substances：

Year:  2021        PMID： 33650246      PMCID： PMC8966952          DOI： 10.1111/jth.15212

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  20 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Dabigatran versus warfarin in patients with mechanical heart valves.

Authors:  John W Eikelboom; Stuart J Connolly; Martina Brueckmann; Christopher B Granger; Arie P Kappetein; Michael J Mack; Jon Blatchford; Kevin Devenny; Jeffrey Friedman; Kelly Guiver; Ruth Harper; Yasser Khder; Maximilian T Lobmeyer; Hugo Maas; Jens-Uwe Voigt; Maarten L Simoons; Frans Van de Werf
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

3.  Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.

Authors:  R Wallin
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

4.  Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Authors:  Mark J Rieder; Alexander P Reiner; Brian F Gage; Deborah A Nickerson; Charles S Eby; Howard L McLeod; David K Blough; Kenneth E Thummel; David L Veenstra; Allan E Rettie
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 5.  The vitamin K cycle.

Authors:  D W Stafford
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

6.  The largest prospective warfarin-treated cohort supports genetic forecasting.

Authors:  Mia Wadelius; Leslie Y Chen; Jonatan D Lindh; Niclas Eriksson; Mohammed J R Ghori; Suzannah Bumpstead; Lennart Holm; Ralph McGinnis; Anders Rane; Panos Deloukas
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

7.  A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.

Authors:  Gregory M Cooper; Julie A Johnson; Taimour Y Langaee; Hua Feng; Ian B Stanaway; Ute I Schwarz; Marylyn D Ritchie; C Michael Stein; Dan M Roden; Joshua D Smith; David L Veenstra; Allan E Rettie; Mark J Rieder
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

8.  Cyclooctatetraene: A Bioactive Cubane Paradigm Complement.

Authors:  Hui Xing; Sevan D Houston; Xuejie Chen; Sussan Ghassabian; Tyler Fahrenhorst-Jones; Andy Kuo; Cody-Ellen P Murray; Kyna-Anne Conn; Kara N Jaeschke; Da-Yun Jin; Cielo Pasay; Paul V Bernhardt; Jed M Burns; John Tsanaktsidis; G Paul Savage; Glen M Boyle; James J De Voss; James McCarthy; Gimme H Walter; Thomas H J Burne; Maree T Smith; Jian-Ke Tie; Craig M Williams
Journal:  Chemistry       Date:  2019-01-25       Impact factor: 5.236

Review 9.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

10.  Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.

Authors:  Ashley Chen; Eric Stecker; Bruce A Warden
Journal:  J Am Heart Assoc       Date:  2020-06-15       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.